Artikel
EyeRisk study – risk factors for AMD phenotypes and progression?
Suche in Medline nach
Autoren
Veröffentlicht: | 5. Februar 2020 |
---|
Gliederung
Text
The H2020 funded EYE-RISK project aimed to identify frequency and morbidity of AMD in Europe, and to specify who is at risk of developing AMD, who is at risk for progression, why and how risks combine to advance progression, and what we can do to lower the risk.
Existing epidemiologic data from >45,000 individuals aged 40+ from ten countries in Europe were harmonized and entered into a common database. Prevalence, visual decline, genetic and non-genetic risk factors were investigated and analysed for geographic differences and time trends.
We found that AMD will become an even more significant health problem in Europe in the near future and that long term visual function of AMD continues to be poor. Furthermore, we showed that genetic testing combined with environmental factors for AMD can be very predictive and that lipids are implicated in AMD with a surprising direction of effect.